SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Friday reported a loss of $6.7 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 42 cents. Earnings, adjusted for one-time gains and costs, came to $1.04 per share.

The drugmaker posted revenue of $41.8 million in the period.

Ligand expects full-year earnings to be $3.95 per share, with revenue expected to be $170 million.

Ligand shares have declined 20% since the beginning of the year. The stock has dropped 26% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LGND at https://www.zacks.com/ap/LGND

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News